Real-time enrollment status for this metastatic breast cancer (mbc) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:51 AM UTC
| NCT Number | NCT06833853 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Breast Cancer (MBC) |
| Phase | Clinical Trial |
| Target Enrollment | 187 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Menarini Silicon Biosystems, INC |
| Last Updated on CT.gov | March 18, 2026 (Mar 18, 2026) |
As of July 13, 2026: Clinical trial NCT06833853 is currently recruiting participants. This clinical trial study for metastatic breast cancer (mbc) is actively seeking new participants at 1 location across the United States. The study is sponsored by Menarini Silicon Biosystems, INC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06833853 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06833853 was last updated Mar 18, 2026 (March 18, 2026). HelloStudys verifies this status automatically.